摘要 |
<p>The use of hyaluronidase in the manufacturing of a drug for the treatment of conditions of inflammation associated with an increased local synthesis of hyaluronan in a mammal, e.g. in connection with organ grafting. The drug comprises hyaluronidase in an amount giving a daily dosage of from 1 to 20 000 IU/kg body weight when given locally or systemically to a mammal. A method of treating inflammatory conditions associated with an increased local synthesis of hyaluronan by systemic or local treatment with a pharmaceutical comprising hyaluronidase.</p> |